Abstract
Intravesical mitomycin C is an effective agent for treatment of superficial transitional cell carcinoma of the bladder. A 60 to 70 per cent overall response rate has been reported. Its side effects have been minor. We present a case of severe bladder contracture after intravesical therapy with mitomycin C.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 357-358 |
| Number of pages | 2 |
| Journal | Urology |
| Volume | 30 |
| Issue number | 4 |
| DOIs | |
| State | Published - 1987 |
ASJC Scopus subject areas
- Urology
Fingerprint Dive into the research topics of 'Severe bladder contracture in patient receiving intravesical mitomycin C for superficial bladder cancer'. Together they form a unique fingerprint.
Cite this
Baker, W. C., Russo, M. A., & deVere White, R. W. (1987). Severe bladder contracture in patient receiving intravesical mitomycin C for superficial bladder cancer. Urology, 30(4), 357-358. https://doi.org/10.1016/0090-4295(87)90300-1